Bausch Health Companies Inc. (TSX: BHC)

Market Cap	4.22B
Revenue (ttm)	12.80B
Net Income (ttm)	-240.47M
Shares Out	n/a
EPS (ttm)	-0.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,488
Open	11.41
Previous Close	11.45
Day's Range	11.41 - 11.70
52-Week Range	5.45 - 15.43
Beta	0.77
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Thomas Appio
• Employees: 20,270
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BHC

Financial Performance

In 2023, Bausch Health Companies's revenue was $8.76 billion, an increase of 7.79% compared to the previous year's $8.12 billion. Losses were -$592.00 million, 163.1% more than in 2022.

Financial numbers in USD